RE:next wsr credit goodtogoJack's 6 month term was over in August. Did Reliq extend the contract for another waste of money?
Dr. Lisa Crossley reports
RELIQ HEALTH TECHNOLOGIES, INC. ANNOUNCES THAT IT HAS ENGAGED WALL STREET REPORTER FOR INVESTOR MARKETING
Reliq Health Technologies Inc. has engaged Wall Street Reporter, a multiplatform global marketing firm.
"We are very excited to be working with the team at Wall Street Reporter to help us share the Reliq story with a wider audience, particularly in the U.S. investment community," said Dr. Lisa Crossley, chief executive officer of Reliq Health Technologies. "Given the significant growth Reliq expects to achieve this year, this is the perfect time to expand our reach and help more potential new investors learn about our business. We chose Wall Street Reporter as our investor marketing partner because of their strong track record and multiple recent successes with other high-growth-potential firms in the telemedicine sector and beyond."
The company also announces has engaged Jack Marks and Octagon Media Corp., an affiliated company of Wall Street Reporter, for a six-month term to deliver a digital media advertising campaign coupled with an investor marketing program. As compensation, Octagon will receive a payment of $125,000 (U.S.) and has been granted incentive stock options exercisable to purchase up to 650,000 common shares in the capital of the company at an exercise price of $1 (Canadian) per share for a period expiring Feb. 10, 2022.